1Dural A,Busson-Leconiat M,Berger R,et al. As- signment of the TCF-4 (TCF7L2)to human chro- mosome band 10q25.3 [J]. Cytogenet Cell Genet, 2000; 88( 3-4 ) : 264-265.
2van Es JH,Barker N,Clevers H,et al. You Wnt some, you lose some:oneogenes in the Wnt signaling pathway [J]. Curr Opin Genet Dev,2003; 13 ( 1 ) : 28-33.
3Yi F,Brubaker P L,Jin T,el al. TCF4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and gly-cogen synthase kinase-3 beta [J]. J Biol Chem,2005;280 (2): 1457-1464.
4Saxena R, Gianniny L, Burtt NP, et al. Common sin- gle nucleotide polymorplfisms in TCF7L2 are repro- ducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic indi- viduals [J]. Diabetes, 2006; 55 (10) : 2890-2895.
5Groves CJ,Zeggini E,Minton J,et al. Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes suscepti- bility genewith a substantial effect on individual risk [J]. Diabetes, 2006 ; 55 (9) : 2640-2644.
6Grant SF,Thorleifsson G, Reynisdottir I, et al. Vari- ant of transcription factor 7-like2 (TCF7L2)gene confers risk of type 2 diabetes. Nat Genet, 2006; 38 : 320-323.
8M. Horikoshi, K. Hara, C. Ito, ct al. A genetic varia- tion of the transcription factor7-1ike 2 gene is asso- ciated with risk of type 2 diabetes in the Japanese population. Diabetologia, 2007 ; 50: 747-751.
9Chandak GR,Janipalli CS,Bhaskar S,et al. Com- mon variants in the TCF7L2 gene are strongly asso- ciated with type 2 diabetes mellitus in the Indian population [J]. Diabetologia, 2007 ; 50( 1 ) : 63-67.
10Gonz a lez-S a nchez JL, Mart f nez-Larrad MT, Zabena C,et al. Association ofvariants of the TCF7L2 gene with increases in the risk of type 2 diabetes and theproinsulin:insulin ratio in the Spanish population [J]. Diabetologia,2008 ;51 ( 11 ): 1993-1997.
二级参考文献69
1Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 2004,27 : 1047-1053.
2Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 2006,444:840-846.
3Weir GC, Bonner-Weir S. A dominant role for glucose in beta cell compensation of insulin resistance. J Clin Invest, 2007,117 : 81-83.
4Terauchi Y, Takamoto I, Kubota Net al. Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. J Clin Invest, 2007,117:246-257.
5Butler AE, Janson J, Bonner-Weir S, et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes, 2003,52 : 102-110.
6Kloppel G, Lohr M, Habich K, et al. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res, 1985,4 : 110-125.
7de-Koning EJ, Bodkin NL, Hansen BC, et al. Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population. Diabetologia, 1993,36:378-384.
8Yoon KH, Ko SH, Cho JH, et al. Selective β-cell loss and α-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab, 2003,88:2300-2308.
9Sakuraba H, Mizukami H, Yagihashi N, et al. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type Ⅱ diabetic patients. Diabetologia, 2002,45:85-96.
10Del-Prato S, Wishner WJ, Gromada J, et al. Beta-cell mass plasticity in type 2 diabetes. Diabetes Obes Metab, 2004,6:319-331.
